ÂÜÀòÂÒÂ×

David Garrett joins iECURE from Dynacure, where he served as chief financial officer and managed a successful Series C raise of €58 million and led its IPO process. Previously, he held various roles at Nabriva Therapeutics, including vice president, corporate controller and head of investor relations and senior director, business planning and analysis. At Nabriva, Mr. Garrett led all Wall Street-facing activities, completed over $150 million in equity capital raises and oversaw all SEC reporting and compliance functions. He was also responsible for leading Nabriva’s redomicile from Austria to Ireland. Prior to Nabriva, Mr. Garrett held senior-level finance roles at Covis Pharmaceuticals, Auxilium Pharmaceuticals and ViroPharma and was a manager at KPMG. Mr. Garrett received an MBA and B.S. in accountancy from Villanova University and is a certified public accountant in Pennsylvania.